Vycor Medical Inc
VYCO· OTC
Released Apr 13, 2022, during market hours
10-K filed Apr 13, 2022, 103 days after period end · 0001493152-22-009797
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Revenue | $273.72K | $291.62K | $307.45K | $426.35K |
| Net Income | -$187.06K | -$200.36K |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| -$220.99K |
| -$481.96K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.